1-5 of 5
Tapio Visakorpi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy

Helle Kristensen, Christa Haldrup, Siri Strand, Kamilla Mundbjerg, Martin M. Mortensen, Kasper Thorsen, Marie Stampe Ostenfeld, Peter J. Wild, Christian Arsov, Wolfgang Goering, Tapio Visakorpi, Lars Egevad, Johan Lindberg, Henrik Grönberg, Søren Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (8): 2169–2181.
https://doi.org/10.1158/1078-0432.CCR-13-2642
Published: 15 April 2014
View article titled, Hypermethylation of the <em>GABRE∼miR-452∼miR-224</em> Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
Open the PDF for Hypermethylation of the <em>GABRE∼miR-452∼miR-224</em> Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer

Katri A. Leinonen, Teemu T. Tolonen, Hazel Bracken, Ulf-Håkan Stenman, Teuvo L.J. Tammela, Outi R. Saramäki, Tapio Visakorpi
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2845–2851.
https://doi.org/10.1158/1078-0432.CCR-09-2505
Published: 13 May 2010
View article titled, Association of SPINK1 Expression and <em>TMPRSS2:ERG</em> Fusion with Prognosis in Endocrine-Treated Prostate Cancer
Open the PDF for Association of SPINK1 Expression and <em>TMPRSS2:ERG</em> Fusion with Prognosis in Endocrine-Treated Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Outi R. Saramäki, Anna E. Harjula, Paula M. Martikainen, Robert L. Vessella, Teuvo L.J. Tammela, Tapio Visakorpi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3395–3400.
https://doi.org/10.1158/1078-0432.CCR-07-2051
Published: 02 June 2008
View article titled, <em>TMPRSS2</em>:<em>ERG</em> Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Open the PDF for <em>TMPRSS2</em>:<em>ERG</em> Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis in another window
Journal Articles

Expression of Androgen Receptor Coregulators in Prostate Cancer

Marika J. Linja, Kati P. Porkka, Zhikang Kang, Kimmo J. Savinainen, Olli A. Jänne, Teuvo L. J. Tammela, Robert L. Vessella, Jorma J. Palvimo, Tapio Visakorpi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 1032–1040.
https://doi.org/10.1158/1078-0432.CCR-0990-3
Published: 10 February 2004
View article titled, Expression of Androgen Receptor Coregulators in Prostate Cancer
Open the PDF for Expression of Androgen Receptor Coregulators in Prostate Cancer in another window
Journal Articles

Identification of Patients with Transitional Cell Carcinoma of the Bladder Overexpressing ErbB2, ErbB3, or Specific ErbB4 Isoforms: Real-Time Reverse Transcription-PCR Analysis in Estimation of ErbB Receptor Status from Cancer Patients

Teemu T. Junttila, Matti Laato, Tero Vahlberg, Karl-Ove Söderström, Tapio Visakorpi, Jorma Isola, Klaus Elenius
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5346–5357.
Published: 12 November 2003
View article titled, Identification of Patients with Transitional Cell Carcinoma of the Bladder Overexpressing ErbB2, ErbB3, or Specific ErbB4 Isoforms: <subtitle>Real-Time Reverse Transcription-PCR Analysis in Estimation of ErbB Receptor Status from Cancer Patients</subtitle>
Open the PDF for Identification of Patients with Transitional Cell Carcinoma of the Bladder Overexpressing ErbB2, ErbB3, or Specific ErbB4 Isoforms: <subtitle>Real-Time Reverse Transcription-PCR Analysis in Estimation of ErbB Receptor Status from Cancer Patients</subtitle> in another window